GLP1R and type 2 diabetes mellitus: In conclusion, we confirmed in vivo that berberine has the effect of treating T2DM and enhancing the function of islet β cell, and then showed that this effect is produced by activating the GLP-1/GLP-1R/PKA signal pathway in the intestine and islet.